Radiologic and molecular remission of follicular T cell lymphoma treated with lenalidomide

被引：1
|
作者：
Kwong, Yok-Lam [1 ]
机构：
[1] Queen Mary Hosp, Dept Med, Professorial Block,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China
来源：
ANNALS OF HEMATOLOGY | 2017年 / 96卷 / 03期
关键词：
NON-HODGKIN-LYMPHOMA; PHASE-2; CLINICAL-TRIAL; GROWTH-PATTERN; OPEN-LABEL; INVOLVEMENT; MONOTHERAPY; MULTICENTER;
D O I：
10.1007/s00277-016-2873-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：513 / 515
页数：3
相关论文
共 50 条
  • [21] High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy
    Hirayama, Alexandre V.
    Gauthier, Jordan
    Hay, Kevin A.
    Voutsinas, Jenna M.
    Wu, Qian
    Pender, Barbara S.
    Hawkins, Reed M.
    Vakil, Aesha
    Steinmetz, Rachel N.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2019, 134 (07) : 636 - 640
  • [22] Dual epigenetic therapy plus chemotherapy in peripheral T cell lymphoma with T follicular helper phenotype
    Atallah-Yunes, Suheil Albert
    Wang, Yucai
    MED, 2024, 5 (11): : 1335 - 1337
  • [23] Follicular T-cell lymphoma: a short review with brief discussion of other nodal lymphomas/lymphoproliferative disorders of T-follicular helper cell origin
    Ramos, Josean
    Ward, Nicholas
    JOURNAL OF HEMATOPATHOLOGY, 2021, 14 (04) : 261 - 268
  • [24] Primary cutaneous follicular helper T-cell lymphoma
    Santonja, Carlos
    Soto, Carlos
    Manso, Rebeca
    Requena, Luis
    Angel Piris, Miguel
    Maria Rodriguez-Pinilla, Socorro
    JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (02) : 164 - 170
  • [25] The landscape of T-cell engagers for the treatment of follicular lymphoma
    Rivas-Delgado, Alfredo
    Landego, Ivan
    Falchi, Lorenzo
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [26] Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma
    Stuckey, Ruth
    Luzardo Henriquez, Hugo
    de la Nuez Melian, Haridian
    Rivero Vera, Jose Carlos
    Bilbao-Sieyro, Cristina
    Gomez-Casares, Maria Teresa
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2023, 14 (04): : 160 - 170
  • [27] A comprehensive review of lenalidomide in B-cell non-Hodgkin lymphoma
    Arora, Mili
    Gowda, Sonia
    Tuscano, Joseph
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (04) : 209 - 221
  • [28] Checking in on Lenalidomide in Diffuse Large B Cell Lymphoma
    Goldfinger, Mendel
    Xu, Mina
    Bertino, Joseph R.
    Cooper, Dennis L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (06) : E307 - E311
  • [29] The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines
    Cosenza, Maria
    Civallero, Monica
    Fiorcari, Stefania
    Pozzi, Samantha
    Marcheselli, Luigi
    Bari, Alessia
    Ferri, Paola
    Sacchi, Stefano
    CANCER BIOLOGY & THERAPY, 2016, 17 (10) : 1094 - 1106
  • [30] Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
    Lemonnier, Francois
    Safar, Violaine
    Beldi-Ferchiou, Asma
    Cottereau, Anne-Segolene
    Bachy, Emmanuel
    Cartron, Guillaume
    Fataccioli, Virginie
    Pelletier, Laura
    Robe, Cyrielle
    Letourneau, Audrey
    Missiaglia, Edoardo
    Fourati, Slim
    Moles-Moreau, Marie-Pierre
    Delmer, Alain
    Bouabdallah, Reda
    Voillat, Laurent
    Becker, Stephanie
    Bossard, Celine
    Parrens, Marie
    Casasnovas, Olivier
    Cacheux, Victoria
    Regny, Caroline
    Camus, Vincent
    Delfau-Larue, Marie-Helene
    Meignan, Michel
    de Leval, Laurence
    Gaulard, Philippe
    Haioun, Corinne
    BLOOD ADVANCES, 2021, 5 (02) : 539 - 548
12345